,reactionoutcome,reactionmeddraversionpt,reactionmeddrapt,safetyreportid
0,6,22.1,Dermatitis,17165479
1,3,22.1,Rash,17165479
2,6,22.1,Liver injury,17165479
0,6,22.1,Immune system disorder,17165529
1,6,22.1,Product physical issue,17165529
2,6,22.1,Poor quality product administered,17165529
3,6,22.1,Spinal compression fracture,17165529
0,1,22.1,Cerebrovascular accident,17165546
0,6,22.1,Recurrent cancer,17165559
1,3,22.1,Anaemia,17165559
2,6,22.1,Blood pressure increased,17165559
3,6,22.1,Full blood count decreased,17165559
4,6,22.1,Fatigue,17165559
5,2,22.1,Nausea,17165559
6,6,22.1,Dyspnoea,17165559
7,6,22.1,Red blood cell count decreased,17165559
8,3,22.1,Constipation,17165559
9,3,22.1,Headache,17165559
10,6,22.1,Intentional product misuse,17165559
0,5,22.1,Death,17165582
0,6,22.1,Incision site erythema,17165592
1,6,22.1,Pneumonia,17165592
2,6,22.1,Joint swelling,17165592
3,6,22.1,Dental caries,17165592
4,6,22.1,Pyrexia,17165592
5,6,22.1,Fluid retention,17165592
6,6,22.1,Alopecia,17165592
7,6,22.1,Weight increased,17165592
8,6,22.1,Tooth loss,17165592
9,6,22.1,Product prescribing error,17165592
0,6,22.1,Haemorrhoids,17165597
1,6,22.1,Cardiac failure,17165597
2,6,22.1,Anaemia,17165597
0,2,22.1,Dermatomyositis,17165601
0,6,22.1,Hypotension,17165633
1,6,22.1,Cough,17165633
2,6,22.1,Dyspnoea,17165633
3,6,22.1,Chest discomfort,17165633
4,6,22.1,Hypoxia,17165633
5,6,22.1,Flushing,17165633
0,1,22.1,Erysipelas,17165677
1,1,22.1,Febrile neutropenia,17165677
2,3,22.1,Pyrexia,17165677
0,6,22.1,Overdose,17165679
0,1,22.1,Herpes ophthalmic,17165688
1,1,22.1,Ulcerative keratitis,17165688
0,2,22.1,Nausea,17165724
1,2,22.1,Blood creatinine increased,17165724
2,3,22.1,Ill-defined disorder,17165724
3,6,22.1,Product use in unapproved indication,17165724
4,3,22.1,Chills,17165724
0,6,22.1,Hip surgery,17165733
1,6,22.1,Product use in unapproved indication,17165733
2,6,22.1,Rash,17165733
0,6,22.1,Malaise,17165754
0,5,22.1,Death,17165758
0,6,22.1,Drug ineffective,17165799
1,6,22.1,Extra dose administered,17165799
2,6,22.1,Inappropriate schedule of product administration,17165799
0,5,22.1,Death,17165809
1,1,22.1,Diarrhoea,17165809
0,1,22.1,Dysgeusia,17165831
1,6,22.1,Malignant neoplasm progression,17165831
0,3,22.1,Diarrhoea,17165862
1,3,22.1,Hyperglycaemia,17165862
0,6,22.1,Breast cancer metastatic,17165895
1,6,22.1,Malignant neoplasm progression,17165895
0,6,22.1,Malignant neoplasm progression,17165898
0,6,22.1,Drug intolerance,17165902
1,6,22.1,Treatment failure,17165902
2,6,22.1,Breast cancer metastatic,17165902
0,1,22.1,Bone marrow failure,17165903
0,2,22.1,Pulmonary oedema,17165907
1,6,22.1,Drug resistance,17165907
2,3,22.1,Lung disorder,17165907
3,6,22.1,Weight decreased,17165907
0,5,22.1,Neoplasm progression,17165924
1,5,22.1,Full blood count abnormal,17165924
0,6,22.1,Pleural effusion,17165925
0,3,22.1,Breast cancer metastatic,17165938
0,6,22.1,Drug hypersensitivity,17165946
1,6,22.1,Product use in unapproved indication,17165946
0,3,22.1,Rash,17165962
1,3,22.1,Skin exfoliation,17165962
0,6,22.1,Multiple-drug resistance,17165976
0,2,22.1,Alopecia,17166064
1,6,22.1,Psychological trauma,17166064
0,2,22.1,Alopecia,17166095
0,6,22.1,Emotional distress,17166127
1,2,22.1,Alopecia,17166127
0,2,22.1,Alopecia,17166152
0,1,22.1,Decreased appetite,17166166
1,1,22.1,Neutropenia,17166166
0,3,22.1,Alopecia,17166173
1,6,22.1,Psychological trauma,17166173
0,2,22.1,Renal impairment,17166179
0,3,22.1,Brain oedema,17166234
0,1,22.1,Neutrophil count decreased,17166240
1,6,22.1,Off label use,17166240
0,5,22.1,Breast cancer,17166244
1,5,22.1,Malignant neoplasm progression,17166244
2,6,22.1,Hyperglycaemic hyperosmolar nonketotic syndrome,17166244
0,2,22.1,Colitis ulcerative,17166264
0,5,22.1,Death,17166293
0,,22.1,Hospitalisation,17166300
0,,22.1,Weight decreased,17166301
0,,22.1,Haemoglobin decreased,17166344
1,,22.1,Platelet count decreased,17166344
2,6,22.1,Laboratory test abnormal,17166344
3,,22.1,Haematocrit decreased,17166344
4,,22.1,Neutrophil count decreased,17166344
5,,22.1,White blood cell count decreased,17166344
6,,22.1,Red blood cell count decreased,17166344
0,3,22.1,Pneumonia,17166383
0,3,22.1,Rash macular,17166403
0,3,22.1,Hair colour changes,17166431
1,3,22.1,Alopecia,17166431
2,6,22.1,Psychiatric symptom,17166431
3,3,22.1,Hair texture abnormal,17166431
4,3,22.1,Hair disorder,17166431
5,3,22.1,Madarosis,17166431
0,5,22.1,Upper gastrointestinal haemorrhage,17166440
0,3,22.1,Blood creatinine increased,17166493
1,6,22.1,Scar,17166493
2,6,22.1,Tumour marker increased,17166493
3,3,22.1,Constipation,17166493
4,3,22.1,Hypertension,17166493
5,6,22.1,Asthenia,17166493
6,3,22.1,Diarrhoea,17166493
7,3,22.1,Nausea,17166493
8,6,22.1,Pneumonia,17166493
9,3,22.1,Fatigue,17166493
0,2,22.1,Chest discomfort,17166501
1,2,22.1,Dyspnoea,17166501
2,2,22.1,Drug hypersensitivity,17166501
3,2,22.1,Chills,17166501
4,2,22.1,Feeling cold,17166501
5,2,22.1,Flushing,17166501
0,6,22.1,Blood pressure increased,17166550
1,6,22.1,Chills,17166550
2,6,22.1,Nausea,17166550
3,6,22.1,Abdominal discomfort,17166550
4,6,22.1,Vomiting,17166550
0,6,22.1,Cholangitis,17166551
0,2,22.1,Drug eruption,17166561
0,1,22.1,Head discomfort,17166573
1,1,22.1,Hot flush,17166573
2,1,22.1,Chest discomfort,17166573
0,1,22.1,Diarrhoea,17166594
1,6,22.1,Fatigue,17166594
2,6,22.1,Peripheral swelling,17166594
3,1,22.1,Constipation,17166594
4,6,22.1,Hunger,17166594
5,6,22.1,Dizziness,17166594
0,1,22.1,Chronic kidney disease,17166609
1,1,22.1,Diarrhoea,17166609
0,6,22.1,Subarachnoid haemorrhage,17166610
0,6,22.1,Product use in unapproved indication,17166630
1,2,22.1,Neutropenia,17166630
2,2,22.1,Leukocoria,17166630
3,6,22.1,Off label use,17166630
0,5,22.1,Cardio-respiratory arrest,17166643
0,3,22.1,Bronchitis,17166649
0,6,22.1,Enteritis infectious,17166655
1,6,22.1,Malaise,17166655
2,6,22.1,Diarrhoea,17166655
3,1,22.1,Diarrhoea,17166655
4,6,22.1,Depressed mood,17166655
0,6,22.1,Abdominal discomfort,17166923
1,6,22.1,Diarrhoea,17166923
0,5,22.1,Cardiac failure,17166977
1,2,22.1,Thrombosis,17166977
2,5,22.1,Malignant neoplasm progression,17166977
0,6,22.1,Liver function test abnormal,17167005
1,5,22.1,Death,17167005
0,5,22.1,Malignant neoplasm progression,17167010
0,5,22.1,Death,17167011
0,5,22.1,Death,17167012
0,5,22.1,Malignant neoplasm progression,17167013
0,2,22.1,Psoriasis,17167072
1,2,22.1,Immune-mediated neuropathy,17167072
2,2,22.1,Muscular weakness,17167072
3,2,22.1,Arthralgia,17167072
0,1,22.1,Sepsis,17167198
1,6,22.1,Agranulocytosis,17167198
2,6,22.1,Cellulitis,17167198
3,4,22.1,Open globe injury,17167198
0,1,22.1,Nausea,17167215
1,1,22.1,Anaemia,17167215
2,3,22.1,Aspiration,17167215
3,3,22.1,Platelet count decreased,17167215
4,3,22.1,Hypocalcaemia,17167215
5,1,22.1,Anaemia,17167215
6,1,22.1,Hypomagnesaemia,17167215
0,6,22.1,Fatigue,17167239
0,6,22.1,Visual impairment,17167274
0,5,22.1,Acute hepatic failure,17167275
1,6,22.1,Drug ineffective,17167275
2,6,22.1,Exposure during pregnancy,17167275
3,5,22.1,Respiratory failure,17167275
4,6,22.1,Disease progression,17167275
0,3,22.1,Neutropenia,17167279
0,1,22.1,Pruritus,17167281
1,1,22.1,Sense of oppression,17167281
2,1,22.1,Hyperaemia,17167281
0,1,22.1,White blood cell count decreased,17167304
1,6,22.1,Anal haemorrhage,17167304
2,2,22.1,Thrombocytopenia,17167304
3,1,22.1,Febrile neutropenia,17167304
4,2,22.1,Anaemia,17167304
5,6,22.1,Frequent bowel movements,17167304
6,6,22.1,Anal incontinence,17167304
0,1,22.1,Pancytopenia,17167313
0,3,22.1,Myeloid leukaemia,17167317
0,6,22.1,Cardiac failure,17167329
1,5,22.1,Malignant neoplasm progression,17167329
0,6,22.1,Hypoxia,17167357
1,6,22.1,Pulmonary embolism,17167357
0,6,22.1,Thrombosis,17167563
1,6,22.1,Condition aggravated,17167563
2,3,22.1,Fatigue,17167563
3,6,22.1,Asthenia,17167563
4,6,22.1,Underdose,17167563
5,6,22.1,Product use issue,17167563
6,6,22.1,Malaise,17167563
0,3,22.1,Asthenia,17167580
1,6,22.1,Fall,17167580
2,3,22.1,Mobility decreased,17167580
3,6,22.1,Taste disorder,17167580
4,3,22.1,Contusion,17167580
5,6,22.1,Weight decreased,17167580
6,3,22.1,Fatigue,17167580
0,6,22.1,Cerebral infarction,17167591
1,6,22.1,Cerebral thrombosis,17167591
0,1,22.1,Hepatotoxicity,17167619
1,3,22.1,Neutropenia,17167619
2,1,22.1,Leukopenia,17167619
0,1,22.1,Pyrexia,17167629
1,2,22.1,Erythema,17167629
2,2,22.1,Anxiety,17167629
3,2,22.1,Rash,17167629
4,2,22.1,Appetite disorder,17167629
5,2,22.1,Depression,17167629
6,6,22.1,Laboratory test abnormal,17167629
7,1,22.1,Bacterial infection,17167629
8,3,22.1,Pruritus,17167629
9,6,22.1,Somnolence,17167629
10,2,22.1,Urinary tract infection,17167629
11,1,22.1,Kidney infection,17167629
12,2,22.1,Pain,17167629
13,2,22.1,Fatigue,17167629
14,2,22.1,Dyspnoea,17167629
0,1,22.1,Seizure,17167638
1,3,22.1,Nausea,17167638
2,6,22.1,Electrocardiogram ST segment elevation,17167638
3,1,22.1,Vomiting,17167638
4,1,22.1,Pulmonary embolism,17167638
0,6,22.1,Rash,17167650
0,6,22.1,Pain,17167653
1,6,22.1,Therapeutic product effect incomplete,17167653
2,6,22.1,Fatigue,17167653
3,6,22.1,Prostate cancer,17167653
0,5,22.1,Interstitial lung disease,17167654
0,5,22.1,Death,17167676
1,6,22.1,Myalgia,17167676
2,6,22.1,Headache,17167676
3,6,22.1,Haemorrhoids,17167676
4,6,22.1,Rash,17167676
5,6,22.1,Disease progression,17167676
6,6,22.1,Infection,17167676
7,6,22.1,Arrhythmia supraventricular,17167676
8,6,22.1,Thrombocytopenia,17167676
9,6,22.1,Chest pain,17167676
10,6,22.1,Haemoptysis,17167676
11,6,22.1,Pain,17167676
12,6,22.1,Dyspnoea,17167676
13,6,22.1,Vomiting,17167676
14,6,22.1,Constipation,17167676
15,6,22.1,Oesophagitis,17167676
16,6,22.1,Hyperkalaemia,17167676
17,6,22.1,Fatigue,17167676
18,6,22.1,Abdominal pain,17167676
19,6,22.1,Dry eye,17167676
20,6,22.1,Skin exfoliation,17167676
21,6,22.1,Muscle spasms,17167676
22,6,22.1,Hyperglycaemia,17167676
23,6,22.1,Oedema,17167676
24,6,22.1,Nausea,17167676
25,6,22.1,Decreased appetite,17167676
26,6,22.1,Pruritus,17167676
27,6,22.1,Alopecia,17167676
28,6,22.1,Deafness,17167676
29,6,22.1,Anaemia,17167676
30,6,22.1,Sepsis,17167676
31,6,22.1,Dehydration,17167676
32,6,22.1,Neuropathy peripheral,17167676
33,6,22.1,Muscular weakness,17167676
34,6,22.1,Cough,17167676
35,6,22.1,Arthralgia,17167676
36,6,22.1,Ill-defined disorder,17167676
37,6,22.1,Granulocytopenia,17167676
38,6,22.1,Stomatitis,17167676
39,6,22.1,Diarrhoea,17167676
40,6,22.1,Hot flush,17167676
41,6,22.1,Hypotension,17167676
42,6,22.1,Haematuria,17167676
43,6,22.1,Insomnia,17167676
0,6,22.1,Cardiac disorder,17167726
0,6,22.1,Cancer pain,17167744
0,2,22.1,Headache,17167783
1,6,22.1,Anxiety,17167783
2,6,22.1,Memory impairment,17167783
3,6,22.1,Delirium,17167783
0,5,22.1,Febrile neutropenia,17167810
0,2,22.1,Pneumothorax,17167834
0,1,22.1,Cytokine storm,17167835
1,1,22.1,Viral rash,17167835
0,2,22.1,Throat tightness,17167852
0,1,22.1,Anaphylactic reaction,17167856
1,1,22.1,Dysphagia,17167856
2,1,22.1,Metastases to lung,17167856
3,1,22.1,Hypersensitivity,17167856
0,3,22.1,Cerebral infarction,17167877
0,5,22.1,Interstitial lung disease,17167944
0,6,22.1,Surgery,17167984
1,6,22.1,Product availability issue,17167984
0,2,22.1,Musculoskeletal toxicity,17168025
1,2,22.1,Myopathy,17168025
2,2,22.1,Toxicity to various agents,17168025
3,2,22.1,Pain in extremity,17168025
4,2,22.1,Rhabdomyolysis,17168025
5,2,22.1,Asthenia,17168025
6,2,22.1,Arthralgia,17168025
7,2,22.1,Myalgia,17168025
8,2,22.1,Muscular weakness,17168025
9,6,22.1,Drug interaction,17168025
0,2,22.1,Musculoskeletal pain,17168060
1,6,22.1,Middle insomnia,17168060
2,6,22.1,Abdominal distension,17168060
3,6,22.1,Diarrhoea,17168060
4,1,22.1,Electrocardiogram QT prolonged,17168060
0,2,22.1,Optic neuritis,17168113
0,5,22.1,Death,17168115
0,6,22.1,Dysarthria,17168118
1,6,22.1,Lip pain,17168118
0,3,22.1,Type 1 diabetes mellitus,17168156
1,6,22.1,Off label use,17168156
2,6,22.1,Inappropriate schedule of product administration,17168156
0,6,22.1,Stevens-Johnson syndrome,17168192
0,1,22.1,Hypoglycaemic coma,17168205
0,6,22.1,Fracture,17168230
1,3,22.1,Proteinuria,17168230
0,6,22.1,Pericarditis,17168258
0,6,22.1,Muscle spasms,17168589
1,6,22.1,Muscle contractions involuntary,17168589
2,6,22.1,Decreased vibratory sense,17168589
3,6,22.1,Myotonia,17168589
4,6,22.1,Paraesthesia,17168589
0,2,22.1,Acne,17168599
0,1,22.1,Hypothyroidism,17168609
1,1,22.1,Neuropathy peripheral,17168609
2,1,22.1,Acute motor axonal neuropathy,17168609
3,1,22.1,Adrenal insufficiency,17168609
4,1,22.1,Cerebral disorder,17168609
0,1,22.1,Erythropenia,17168680
1,1,22.1,Renal failure,17168680
0,1,22.1,Rash,17168684
1,1,22.1,Infusion related reaction,17168684
2,1,22.1,Asthenia,17168684
0,1,22.1,Pneumonia,17168710
0,1,22.1,Breast cancer metastatic,17168712
1,5,22.1,Breast cancer metastatic,17168712
0,5,22.1,Death,17168748
0,2,22.1,Asthenia,17168763
1,2,22.1,Hepatic function abnormal,17168763
0,2,22.1,Myocardial infarction,17168775
0,5,22.1,Unresponsive to stimuli,17168780
1,5,22.1,Anaemia,17168780
2,5,22.1,Fatigue,17168780
3,5,22.1,Myelodysplastic syndrome,17168780
4,5,22.1,Second primary malignancy,17168780
5,5,22.1,Sepsis,17168780
6,5,22.1,Non-Hodgkin^s lymphoma,17168780
7,5,22.1,Hypotension,17168780
8,5,22.1,Laboratory test abnormal,17168780
9,5,22.1,Pancytopenia,17168780
0,,22.1,Death,17168795
0,,22.1,Unresponsive to stimuli,17168811
1,,22.1,Seizure,17168811
2,,22.1,Posterior reversible encephalopathy syndrome,17168811
3,,22.1,Haematuria,17168811
4,,22.1,Abdominal pain,17168811
5,,22.1,Acute kidney injury,17168811
0,6,22.1,Hyperglycaemia,17168822
0,,22.1,Urinary tract infection,17168824
0,6,22.1,Renal impairment,17168837
0,,22.1,Haemorrhage,17168855
1,,22.1,Dehydration,17168855
0,2,22.1,Hip surgery,17168884
1,6,22.1,Radiotherapy,17168884
0,6,22.1,Neuropathy peripheral,17168896
1,6,22.1,Pain,17168896
0,,22.1,Hospitalisation,17168908
0,6,22.1,Anaemia,17168911
1,6,22.1,Leukopenia,17168911
2,6,22.1,Metastases to bone,17168911
3,6,22.1,Tubulointerstitial nephritis,17168911
4,6,22.1,Pyrexia,17168911
5,6,22.1,Diarrhoea,17168911
6,6,22.1,Proteinuria,17168911
7,6,22.1,Rash,17168911
8,6,22.1,Metastases to lung,17168911
9,6,22.1,Breast mass,17168911
10,6,22.1,Thrombocytopenia,17168911
11,6,22.1,Ascariasis,17168911
12,6,22.1,Blood lactate dehydrogenase increased,17168911
0,6,22.1,Inappropriate schedule of product administration,17168967
1,5,22.1,Death,17168967
0,,22.1,Fatigue,17168999
1,,22.1,Asthenia,17168999
0,1,22.1,Cytokine release syndrome,17169014
1,1,22.1,Rash,17169014
0,6,22.1,Ulcerative keratitis,17169024
1,6,22.1,Hepatic failure,17169024
2,6,22.1,Hepatic function abnormal,17169024
0,,22.1,Chronic obstructive pulmonary disease,17169047
1,,22.1,Cardiac failure congestive,17169047
0,5,22.1,Ovarian cancer,17169079
0,1,22.1,Sinus bradycardia,17169092
0,,22.1,Palpitations,17169155
0,1,22.1,Off label use,17169157
1,1,22.1,Contraindicated product administered,17169157
2,1,22.1,Retinal detachment,17169157
3,1,22.1,Headache,17169157
4,1,22.1,Intraocular pressure increased,17169157
0,,22.1,Stomatitis,17169161
1,,22.1,Constipation,17169161
0,1,22.1,Lower respiratory tract infection,17169193
1,6,22.1,Off label use,17169193
0,5,22.1,Respiratory failure,17169238
1,5,22.1,Circulatory collapse,17169238
0,6,22.1,Drug interaction,17169256
1,2,22.1,Haemoglobin abnormal,17169256
2,2,22.1,Gastrooesophageal reflux disease,17169256
0,1,22.1,Product use issue,17169263
1,5,22.1,Death,17169263
0,3,22.1,Metastasis,17169311
1,3,22.1,Hypocalcaemia,17169311
0,6,22.1,Blood count abnormal,17169341
0,6,22.1,Palpitations,17169375
1,6,22.1,Blood potassium decreased,17169375
2,6,22.1,Dizziness,17169375
3,6,22.1,Headache,17169375
4,6,22.1,Fatigue,17169375
5,6,22.1,Blood magnesium decreased,17169375
0,5,22.1,Death,17169417
0,5,22.1,Metastases to lung,17169420
1,5,22.1,Anaemia,17169420
2,5,22.1,Pallor,17169420
3,5,22.1,Death,17169420
4,5,22.1,Prostate cancer,17169420
5,5,22.1,Dyspnoea,17169420
6,5,22.1,Ureteric rupture,17169420
7,5,22.1,Hyperkalaemia,17169420
8,5,22.1,Acute kidney injury,17169420
9,5,22.1,Malaise,17169420
10,5,22.1,Hydronephrosis,17169420
11,5,22.1,Abdominal pain,17169420
12,5,22.1,Respiratory failure,17169420
0,6,22.1,Hyperglycaemia,17169456
0,5,22.1,Death,17169475
0,6,22.1,Hyperglycaemia,17169492
1,1,22.1,Hyperglycaemia,17169492
0,6,22.1,Intentional product use issue,17169502
1,6,22.1,Artificial menopause,17169502
2,6,22.1,Off label use,17169502
3,6,22.1,Neoplasm progression,17169502
0,6,22.1,Neutropenia,17169514
1,6,22.1,Blood test abnormal,17169514
2,6,22.1,Lower respiratory tract infection,17169514
3,6,22.1,Constipation,17169514
4,6,22.1,Blood thyroid stimulating hormone increased,17169514
0,6,22.1,Primary pulmonary melanoma,17169520
1,6,22.1,Second primary malignancy,17169520
0,2,22.1,Condition aggravated,17169526
1,2,22.1,Acute kidney injury,17169526
0,3,22.1,Neuropathy peripheral,17169585
1,3,22.1,Gait inability,17169585
2,3,22.1,Asthenia,17169585
3,6,22.1,Rheumatoid arthritis,17169585
0,6,22.1,Drug resistance,17169603
1,6,22.1,Malignant neoplasm progression,17169603
0,5,22.1,Malignant neoplasm progression,17169623
0,1,22.1,Cataract,17169636
1,6,22.1,Blindness,17169636
0,5,22.1,Death,17169642
0,6,22.1,Accidental overdose,17169644
0,3,22.1,Nausea,17169706
1,3,22.1,Abdominal discomfort,17169706
0,1,22.1,Liver disorder,17169724
1,1,22.1,Interstitial lung disease,17169724
0,6,22.1,Epistaxis,17169792
1,6,22.1,Contusion,17169792
0,3,22.1,Therapeutic product effect incomplete,17169806
0,6,22.1,Malaise,17169813
0,6,22.1,Oedema,17169830
1,6,22.1,Weight increased,17169830
0,2,22.1,Fatigue,17169833
0,6,22.1,Nasopharyngitis,17169834
0,6,22.1,Fatigue,17169835
1,6,22.1,Asthenia,17169835
2,6,22.1,Dry skin,17169835
3,6,22.1,Pruritus,17169835
0,3,22.1,Madarosis,17169838
1,3,22.1,Alopecia,17169838
2,3,22.1,Hair texture abnormal,17169838
3,3,22.1,Hair disorder,17169838
4,3,22.1,Hair colour changes,17169838
0,1,22.1,Fatigue,17169871
1,1,22.1,Pneumatosis intestinalis,17169871
2,1,22.1,Dysphonia,17169871
3,1,22.1,Diarrhoea,17169871
4,1,22.1,Decreased appetite,17169871
0,3,22.1,Alopecia,17169894
0,3,22.1,Hair disorder,17169896
1,3,22.1,Alopecia,17169896
2,3,22.1,Hair colour changes,17169896
3,3,22.1,Hair texture abnormal,17169896
4,6,22.1,Anxiety,17169896
5,6,22.1,Depression,17169896
6,3,22.1,Madarosis,17169896
0,3,22.1,Alopecia,17169903
1,3,22.1,Hair disorder,17169903
2,3,22.1,Hair texture abnormal,17169903
3,3,22.1,Madarosis,17169903
4,3,22.1,Hair colour changes,17169903
0,1,22.1,Dizziness,17169916
1,1,22.1,Hypoacusis,17169916
2,1,22.1,Headache,17169916
0,,22.1,Hypoalbuminaemia,17169928
1,,22.1,Renal impairment,17169928
2,3,22.1,Hypertension,17169928
3,3,22.1,Proteinuria,17169928
4,,22.1,Pneumonia,17169928
0,3,22.1,Hypertension,17169964
1,6,22.1,Decreased appetite,17169964
2,,22.1,Aspiration pleural cavity,17169964
3,,22.1,Pain,17169964
4,6,22.1,Vomiting,17169964
5,,22.1,Malaise,17169964
6,6,22.1,Nausea,17169964
7,6,22.1,Hypersomnia,17169964
8,6,22.1,Weight decreased,17169964
9,6,22.1,Blood pressure increased,17169964
0,,22.1,Arthralgia,17169968
1,,22.1,Pain,17169968
2,3,22.1,General physical health deterioration,17169968
3,,22.1,Metastases to central nervous system,17169968
4,3,22.1,Bedridden,17169968
5,,22.1,Fatigue,17169968
6,2,22.1,Dysphonia,17169968
0,6,22.1,Fatigue,17170000
0,6,22.1,Off label use,17170006
1,6,22.1,Dysphagia,17170006
2,6,22.1,Product use in unapproved indication,17170006
0,3,22.1,Hair disorder,17170007
1,3,22.1,Hair colour changes,17170007
2,3,22.1,Alopecia,17170007
3,3,22.1,Hair texture abnormal,17170007
4,3,22.1,Madarosis,17170007
0,6,22.1,Neutrophil count decreased,17170010
1,6,22.1,White blood cell count decreased,17170010
0,3,22.1,Alopecia,17170011
1,3,22.1,Madarosis,17170011
2,3,22.1,Hair texture abnormal,17170011
3,3,22.1,Hair disorder,17170011
4,3,22.1,Hair colour changes,17170011
0,3,22.1,Hair colour changes,17170014
1,3,22.1,Alopecia,17170014
2,3,22.1,Hair disorder,17170014
3,3,22.1,Hair texture abnormal,17170014
0,6,22.1,Blood count abnormal,17170015
1,6,22.1,Dysgraphia,17170015
2,6,22.1,Tremor,17170015
0,6,22.1,Oral herpes,17170020
1,6,22.1,Stomatitis,17170020
0,6,22.1,Pyrexia,17170025
0,6,22.1,Laboratory test abnormal,17170028
0,3,22.1,Hair colour changes,17170030
1,3,22.1,Hair disorder,17170030
2,3,22.1,Alopecia,17170030
3,3,22.1,Hair texture abnormal,17170030
0,3,22.1,Pain in extremity,17170032
1,3,22.1,Headache,17170032
2,3,22.1,Muscular weakness,17170032
3,6,22.1,Decreased appetite,17170032
4,6,22.1,Malaise,17170032
5,6,22.1,Hyperhidrosis,17170032
6,3,22.1,Gait disturbance,17170032
7,6,22.1,Nausea,17170032
8,6,22.1,Hunger,17170032
0,6,22.1,White blood cell count decreased,17170033
1,6,22.1,Blood count abnormal,17170033
0,3,22.1,Madarosis,17170035
1,3,22.1,Hair texture abnormal,17170035
2,3,22.1,Hair disorder,17170035
3,3,22.1,Alopecia,17170035
4,3,22.1,Hair colour changes,17170035
0,1,22.1,Taste disorder,17170036
1,1,22.1,Vomiting,17170036
2,1,22.1,Constipation,17170036
3,6,22.1,Blood count abnormal,17170036
4,6,22.1,Osteopenia,17170036
5,6,22.1,Condition aggravated,17170036
0,6,22.1,Blood count abnormal,17170038
1,3,22.1,Alopecia,17170038
2,6,22.1,White blood cell count decreased,17170038
3,3,22.1,Neutrophil count decreased,17170038
0,6,22.1,Agitation,17170045
0,5,22.1,Cardio-respiratory arrest,17170076
0,3,22.1,Deafness bilateral,17170091
0,6,22.1,Renal impairment,17170102
0,3,22.1,Diabetes mellitus,17170103
1,6,22.1,Product dose omission,17170103
0,3,22.1,Polyneuropathy,17170106
1,3,22.1,Nausea,17170106
2,1,22.1,Mastoiditis,17170106
3,3,22.1,Constipation,17170106
4,1,22.1,Infected lymphocele,17170106
5,3,22.1,Fatigue,17170106
6,3,22.1,Arthralgia,17170106
7,3,22.1,Intervertebral disc protrusion,17170106
8,3,22.1,Hypertension,17170106
9,1,22.1,Meningitis,17170106
10,3,22.1,Dyspnoea,17170106
0,4,22.1,Pleural effusion,17170111
0,6,22.1,Hot flush,17170148
1,6,22.1,Poor quality sleep,17170148
2,6,22.1,Hypoaesthesia,17170148
3,6,22.1,Paraesthesia,17170148
4,6,22.1,Headache,17170148
5,6,22.1,Fatigue,17170148
0,5,22.1,Febrile neutropenia,17170153
0,6,22.1,Dyspnoea,17170166
1,6,22.1,Anaemia,17170166
2,6,22.1,Hypothyroidism,17170166
0,6,22.1,Dysphonia,17170167
1,,22.1,Acute kidney injury,17170167
2,,22.1,Sepsis,17170167
0,3,22.1,Cardiotoxicity,17170185
1,3,22.1,Hypokinesia,17170185
0,5,22.1,Septic shock,17170213
0,5,22.1,Drug ineffective,17170221
0,6,22.1,Interstitial lung disease,17170273
1,1,22.1,Decreased appetite,17170273
2,1,22.1,Neutrophil count decreased,17170273
3,4,22.1,Interstitial lung disease,17170273
0,1,22.1,Eczema,17170281
1,6,22.1,Drug resistance,17170281
2,6,22.1,Metastasis,17170281
3,1,22.1,Mouth ulceration,17170281
0,6,22.1,Drug intolerance,17170282
1,6,22.1,Product dose omission,17170282
2,6,22.1,Herpes zoster,17170282
3,3,22.1,Nausea,17170282
4,3,22.1,Listless,17170282
5,3,22.1,Pain,17170282
0,6,22.1,Intestinal obstruction,17170291
0,1,22.1,Back pain,17170302
1,2,22.1,Dyspnoea,17170302
2,6,22.1,Musculoskeletal discomfort,17170302
3,6,22.1,Neutropenia,17170302
4,1,22.1,Asthenia,17170302
5,6,22.1,Musculoskeletal chest pain,17170302
6,2,22.1,Spinal pain,17170302
7,6,22.1,Alopecia,17170302
0,6,22.1,Gastroenteritis,17170328
1,3,22.1,Dehydration,17170328
0,6,22.1,Large intestinal ulcer,17170340
1,2,22.1,Colitis,17170340
0,1,22.1,Haemorrhoids,17170352
1,1,22.1,Diarrhoea haemorrhagic,17170352
0,1,22.1,Oral mucosal eruption,17170354
1,5,22.1,Death,17170354
0,5,22.1,Death,17170363
0,1,22.1,Neutrophil count decreased,17170370
1,1,22.1,Pyrexia,17170370
0,1,22.1,Myocardial infarction,17170383
1,3,22.1,Blood cholesterol increased,17170383
0,6,22.1,Malignant neoplasm progression,17170387
0,1,22.1,Product use issue,17170393
1,1,22.1,Haemorrhage,17170393
0,6,22.1,Radiation pneumonitis,17170394
1,1,22.1,Lung disorder,17170394
0,1,22.1,Diarrhoea,17170405
1,6,22.1,Polyneuropathy,17170405
2,1,22.1,Sinus node dysfunction,17170405
0,6,22.1,Gastric cancer,17170409
1,6,22.1,Second primary malignancy,17170409
2,1,22.1,Neutrophil count decreased,17170409
3,1,22.1,White blood cell count decreased,17170409
0,6,22.1,Pruritus,17170425
1,6,22.1,Haemostasis,17170425
2,6,22.1,Brain injury,17170425
3,6,22.1,Fall,17170425
0,6,22.1,Bone marrow failure,17170439
1,6,22.1,Pain,17170439
2,6,22.1,Neutropenia,17170439
0,6,22.1,Hypertension,17170441
1,3,22.1,Infection,17170441
2,1,22.1,Nausea,17170441
3,3,22.1,Dyspnoea,17170441
4,3,22.1,Nausea,17170441
0,5,22.1,Septic shock,17170448
0,6,22.1,Rash,17170478
1,6,22.1,Dizziness,17170478
2,6,22.1,Dyspnoea,17170478
3,6,22.1,Fatigue,17170478
4,6,22.1,Unevaluable event,17170478
5,6,22.1,Weight decreased,17170478
0,6,22.1,Product size issue,17170501
0,6,22.1,Disease progression,17170503
0,5,22.1,Infectious pleural effusion,17170534
1,5,22.1,Sepsis,17170534
2,5,22.1,Impaired healing,17170534
3,5,22.1,Breast cancer,17170534
0,5,22.1,Meningoencephalitis herpetic,17170535
0,6,22.1,Accidental exposure to product,17170538
1,6,22.1,Product leakage,17170538
0,6,22.1,Asthenia,17170539
1,2,22.1,Haematuria,17170539
0,6,22.1,Blood count abnormal,17170545
0,5,22.1,Death,17170558
0,6,22.1,Feeding disorder,17170562
1,5,22.1,Death,17170562
0,3,22.1,General physical health deterioration,17170589
0,2,22.1,Chondrocalcinosis pyrophosphate,17170590
1,2,22.1,Urinary tract infection,17170590
0,6,22.1,Hypertension,17170609
1,6,22.1,Pancytopenia,17170609
2,4,22.1,Posterior reversible encephalopathy syndrome,17170609
3,6,22.1,Depressed level of consciousness,17170609
4,6,22.1,Febrile neutropenia,17170609
0,1,22.1,Lichen sclerosus,17170619
0,5,22.1,Death,17170672
0,5,22.1,Death,17170700
0,6,22.1,Cancer pain,17170718
1,6,22.1,Breast cancer,17170718
2,6,22.1,Malignant neoplasm progression,17170718
3,6,22.1,Interstitial lung disease,17170718
4,6,22.1,Stomatitis,17170718
5,6,22.1,Metastases to liver,17170718
6,6,22.1,Dyspnoea,17170718
0,6,22.1,Liver disorder,17170719
1,6,22.1,Hypertension,17170719
2,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,17170719
3,6,22.1,Hypothyroidism,17170719
0,6,22.1,Proteinuria,17170740
1,2,22.1,Headache,17170740
2,2,22.1,Pain in extremity,17170740
3,6,22.1,Electrocardiogram QT prolonged,17170740
4,6,22.1,Hypertension,17170740
5,2,22.1,Chest pain,17170740
0,6,22.1,Leukopenia,17170775
1,6,22.1,Thrombocytopenia,17170775
0,2,22.1,Interstitial lung disease,17170780
0,2,22.1,Interstitial lung disease,17170781
0,6,22.1,Interstitial lung disease,17170783
0,2,22.1,Interstitial lung disease,17170784
0,2,22.1,Interstitial lung disease,17170790
0,3,22.1,Visual field defect,17170801
1,3,22.1,Visual impairment,17170801
2,3,22.1,Vision blurred,17170801
3,3,22.1,Necrotising retinitis,17170801
0,3,22.1,Peripheral sensorimotor neuropathy,17170804
1,3,22.1,Cardiac failure,17170804
0,1,22.1,General physical health deterioration,17170806
1,4,22.1,Large intestine perforation,17170806
0,6,22.1,Malignant neoplasm progression,17170835
1,6,22.1,Drug ineffective,17170835
0,6,22.1,Malignant neoplasm progression,17170872
1,6,22.1,Drug resistance,17170872
2,6,22.1,Vomiting,17170872
0,6,22.1,Malignant neoplasm progression,17170873
1,6,22.1,Drug resistance,17170873
0,1,22.1,Dehydration,17170919
1,1,22.1,Abdominal pain,17170919
2,1,22.1,Vomiting,17170919
3,6,22.1,Anaemia,17170919
4,1,22.1,Nausea,17170919
5,1,22.1,Decreased appetite,17170919
6,1,22.1,Acute kidney injury,17170919
7,1,22.1,Dyspnoea,17170919
0,5,22.1,Meningoencephalitis herpetic,17170929
0,3,22.1,Cholestasis,17170948
1,3,22.1,Hepatocellular injury,17170948
0,6,22.1,Malignant neoplasm progression,17170956
1,6,22.1,Breast cancer,17170956
2,3,22.1,General physical health deterioration,17170956
0,6,22.1,Pneumonia,17170986
1,6,22.1,Septic shock,17170986
2,5,22.1,Respiratory failure,17170986
3,6,22.1,Pulmonary oedema,17170986
0,1,22.1,Osteonecrosis of jaw,17171058
1,6,22.1,Long QT syndrome,17171058
0,6,22.1,Blood pressure increased,17171399
0,1,22.1,Nephrolithiasis,17171412
0,1,22.1,Dyspnoea,17171420
1,1,22.1,Cardiac failure acute,17171420
2,1,22.1,Anaemia,17171420
0,6,22.1,Product use in unapproved indication,17171454
1,5,22.1,Death,17171454
0,6,22.1,Skin ulcer,17171475
1,6,22.1,Hyperkeratosis,17171475
0,1,22.1,Fracture,17171476
0,5,22.1,Death,17171477
0,3,22.1,Haemoglobin decreased,17171478
1,6,22.1,Hospitalisation,17171478
0,6,22.1,Dehydration,17171487
0,6,22.1,Bone marrow disorder,17171489
1,6,22.1,Sepsis,17171489
2,6,22.1,Breast cancer recurrent,17171489
3,6,22.1,Malignant neoplasm progression,17171489
4,6,22.1,Vein disorder,17171489
0,6,22.1,Rash,17171520
0,6,22.1,Pleural effusion,17171524
1,6,22.1,Hyperglycaemia,17171524
2,6,22.1,Dyspnoea,17171524
3,6,22.1,Rash,17171524
4,2,22.1,Diabetes mellitus,17171524
0,1,22.1,Pulmonary embolism,17171544
0,6,22.1,White blood cell count decreased,17171559
0,3,22.1,Hypotonia,17171575
1,3,22.1,Weight increased,17171575
0,6,22.1,Skin discolouration,17171597
1,6,22.1,Dizziness,17171597
2,6,22.1,Nausea,17171597
3,6,22.1,Mouth haemorrhage,17171597
4,6,22.1,Hospitalisation,17171597
0,5,22.1,Death,17171628
0,6,22.1,Prostatic specific antigen increased,17171666
0,1,22.1,Diarrhoea,17171684
1,3,22.1,Nausea,17171684
2,3,22.1,Epistaxis,17171684
3,3,22.1,Polyneuropathy,17171684
4,1,22.1,Hypokalaemia,17171684
5,3,22.1,Headache,17171684
0,6,22.1,Adverse drug reaction,17171706
1,2,22.1,Blood pressure increased,17171706
0,6,22.1,Hypoaesthesia,17171713
1,6,22.1,Muscular weakness,17171713
0,6,22.1,Oedema peripheral,17171750
1,6,22.1,Feeling hot,17171750
2,6,22.1,Nausea,17171750
3,6,22.1,Cellulitis,17171750
4,6,22.1,Alopecia,17171750
5,6,22.1,Fatigue,17171750
6,6,22.1,Erythema,17171750
7,6,22.1,Pain,17171750
0,3,22.1,Alopecia,17171758
1,6,22.1,Emotional distress,17171758
0,2,22.1,Alopecia,17171759
1,6,22.1,Psychological trauma,17171759
0,6,22.1,Emotional distress,17171775
1,6,22.1,Psychological trauma,17171775
2,2,22.1,Alopecia,17171775
0,6,22.1,Psychological trauma,17171834
1,2,22.1,Alopecia,17171834
0,2,22.1,Alopecia,17171840
1,6,22.1,Psychological trauma,17171840
0,2,22.1,Alopecia,17171849
1,6,22.1,Psychological trauma,17171849
0,3,22.1,Alopecia,17171855
0,3,22.1,Alopecia,17171857
0,3,22.1,Alopecia,17171858
0,2,22.1,Alopecia,17171863
1,6,22.1,Psychological trauma,17171863
0,6,22.1,Psychological trauma,17171866
1,2,22.1,Alopecia,17171866
0,2,22.1,Alopecia,17171876
1,6,22.1,Psychological trauma,17171876
0,3,22.1,Alopecia,17171885
0,6,22.1,Electrocardiogram QT prolonged,17171905
1,6,22.1,Hepatic enzyme increased,17171905
2,6,22.1,Malignant neoplasm progression,17171905
3,6,22.1,Breast cancer,17171905
4,6,22.1,Arrhythmia,17171905
0,1,22.1,Oropharyngeal pain,17171907
1,1,22.1,Pneumonitis,17171907
2,1,22.1,Cough,17171907
3,1,22.1,Neutropenia,17171907
4,3,22.1,Bone pain,17171907
5,3,22.1,Fatigue,17171907
6,1,22.1,Leukopenia,17171907
0,6,22.1,Psychological trauma,17171921
1,3,22.1,Alopecia,17171921
0,2,22.1,Alopecia,17171925
1,6,22.1,Psychological trauma,17171925
0,2,22.1,Alopecia,17171927
1,2,22.1,Emotional distress,17171927
2,6,22.1,Psychological trauma,17171927
0,6,22.1,Psychological trauma,17171944
1,2,22.1,Alopecia,17171944
0,6,22.1,Eructation,17171976
1,1,22.1,Chest pain,17171976
2,1,22.1,Oesophageal obstruction,17171976
3,1,22.1,Dysphagia,17171976
4,1,22.1,Abdominal pain upper,17171976
5,6,22.1,White blood cell count decreased,17171976
6,1,22.1,Oesophageal pain,17171976
7,3,22.1,Abdominal discomfort,17171976
0,6,22.1,Fatigue,17171987
1,6,22.1,Blood alkaline phosphatase increased,17171987
2,6,22.1,Back pain,17171987
3,6,22.1,Pleural effusion,17171987
4,6,22.1,Malignant neoplasm progression,17171987
5,6,22.1,Neutropenia,17171987
6,6,22.1,Metastases to lung,17171987
7,6,22.1,Inappropriate schedule of product administration,17171987
8,1,22.1,Anaemia,17171987
9,6,22.1,Musculoskeletal pain,17171987
10,6,22.1,Metastases to lymph nodes,17171987
11,6,22.1,Blood lactate dehydrogenase increased,17171987
12,6,22.1,Breast cancer,17171987
0,5,22.1,Neoplasm progression,17171988
1,5,22.1,Cardiac failure,17171988
0,3,22.1,Pneumonia,17172021
0,3,22.1,Decreased appetite,17172045
1,3,22.1,Limb injury,17172045
2,3,22.1,Deep vein thrombosis,17172045
3,3,22.1,Fatigue,17172045
4,3,22.1,Alopecia,17172045
0,1,22.1,Rash,17172067
0,6,22.1,Hot flush,17172076
1,6,22.1,Injection site pain,17172076
2,6,22.1,Injection site swelling,17172076
3,6,22.1,Nausea,17172076
0,5,22.1,Pain,17172079
1,5,22.1,Asthenia,17172079
2,5,22.1,Fatigue,17172079
3,5,22.1,Malaise,17172079
0,6,22.1,Musculoskeletal stiffness,17172082
1,6,22.1,Blood potassium decreased,17172082
0,3,22.1,Renal impairment,17172104
1,6,22.1,Rash,17172104
0,3,22.1,Pleural effusion,17172109
1,3,22.1,Bronchiectasis,17172109
2,3,22.1,Pain,17172109
3,3,22.1,Neoplasm progression,17172109
4,3,22.1,Fatigue,17172109
0,1,22.1,Flushing,17172116
1,1,22.1,Feeling abnormal,17172116
0,3,22.1,Prostate cancer,17172139
0,1,22.1,Cardiac arrest,17172176
1,1,22.1,Left ventricular dysfunction,17172176
2,1,22.1,Arrhythmia,17172176
0,3,22.1,Cancer pain,17172182
1,3,22.1,Leukopenia,17172182
2,1,22.1,Stomatitis,17172182
3,1,22.1,Angular cheilitis,17172182
4,5,22.1,Breast cancer metastatic,17172182
5,5,22.1,Malignant neoplasm progression,17172182
0,6,22.1,Arthralgia,17172218
0,,22.1,Malaise,17172239
0,6,22.1,Acute kidney injury,17172247
0,6,22.1,Asthenia,17172280
1,6,22.1,Fatigue,17172280
2,6,22.1,Malaise,17172280
3,6,22.1,Pain,17172280
0,6,22.1,Cerebrovascular accident,17172289
1,6,22.1,Aortic dilatation,17172289
0,3,22.1,Productive cough,17172304
1,3,22.1,Dry mouth,17172304
2,3,22.1,Dry eye,17172304
3,3,22.1,Glaucoma,17172304
4,6,22.1,Eye disorder,17172304
0,5,22.1,Febrile neutropenia,17172347
1,5,22.1,Urosepsis,17172347
0,2,22.1,Erythema,17172370
1,2,22.1,Burning sensation,17172370
0,6,22.1,Device related thrombosis,17172374
1,6,22.1,Insomnia,17172374
2,6,22.1,Cholinergic syndrome,17172374
0,1,22.1,Dyspnoea,17172380
1,1,22.1,Hot flush,17172380
2,1,22.1,Blood pressure decreased,17172380
3,1,22.1,Tachycardia,17172380
4,1,22.1,Oxygen saturation decreased,17172380
0,1,22.1,Embolism,17172401
1,1,22.1,Dehydration,17172401
0,3,22.1,Rectal cancer,17172405
0,3,22.1,Neuropathy peripheral,17172413
1,3,22.1,Myalgia,17172413
2,3,22.1,Bone pain,17172413
0,3,22.1,Infection,17172423
1,3,22.1,Limb injury,17172423
0,5,22.1,Neoplasm progression,17172431
0,6,22.1,Hypothyroidism,17172434
1,6,22.1,Hot flush,17172434
2,6,22.1,Anxiety,17172434
3,6,22.1,Chest discomfort,17172434
4,6,22.1,Mood swings,17172434
5,6,22.1,Neutrophil count decreased,17172434
6,6,22.1,Full blood count decreased,17172434
7,6,22.1,Neoplasm progression,17172434
8,6,22.1,White blood cell count decreased,17172434
0,3,22.1,Febrile neutropenia,17172482
1,3,22.1,Thrombocytopenia,17172482
0,6,22.1,Anxiety,17172499
1,6,22.1,Emotional distress,17172499
2,3,22.1,Alopecia,17172499
3,6,22.1,Pain,17172499
4,6,22.1,Impaired quality of life,17172499
0,6,22.1,Aspartate aminotransferase increased,17172552
1,6,22.1,Blood bilirubin increased,17172552
2,6,22.1,Neutropenia,17172552
3,5,22.1,Death,17172552
4,6,22.1,Platelet count decreased,17172552
0,6,22.1,Hypertension,17172563
1,6,22.1,Pleural effusion,17172563
0,3,22.1,Abdominal pain,17172588
0,6,22.1,Neurotoxicity,17172617
1,6,22.1,Muscle contractions involuntary,17172617
2,6,22.1,Paraesthesia,17172617
3,6,22.1,Muscle spasms,17172617
4,6,22.1,Decreased vibratory sense,17172617
5,6,22.1,Myotonia,17172617
0,1,22.1,Infection,17172638
1,1,22.1,Febrile neutropenia,17172638
0,6,22.1,Tachycardia,17172654
1,6,22.1,Arrhythmia,17172654
0,6,22.1,Psychological trauma,17172663
1,3,22.1,Alopecia,17172663
2,6,22.1,Emotional distress,17172663
0,6,22.1,Blood count abnormal,17172680
0,6,22.1,Psychological trauma,17172731
1,2,22.1,Alopecia,17172731
0,6,22.1,Psychological trauma,17172751
1,2,22.1,Alopecia,17172751
0,6,22.1,Blood bilirubin increased,17172761
1,6,22.1,Inappropriate schedule of product administration,17172761
2,6,22.1,Product use in unapproved indication,17172761
0,6,22.1,Psychological trauma,17172766
1,2,22.1,Alopecia,17172766
0,3,22.1,Alopecia,17172800
0,6,22.1,Psychological trauma,17172803
1,2,22.1,Alopecia,17172803
2,6,22.1,Emotional distress,17172803
0,6,22.1,Haemorrhage urinary tract,17172857
0,6,22.1,Hot flush,17172871
1,6,22.1,Cold sweat,17172871
0,1,22.1,Immune-mediated pneumonitis,17172900
0,6,22.1,Bone marrow failure,17172938
1,6,22.1,Vomiting,17172938
2,1,22.1,Blood pressure increased,17172938
3,6,22.1,Nausea,17172938
0,3,22.1,Asthenia,17172941
1,3,22.1,Hepatic pain,17172941
2,3,22.1,Abdominal pain upper,17172941
3,3,22.1,Weight decreased,17172941
0,3,22.1,Memory impairment,17172979
1,3,22.1,Blood pressure increased,17172979
2,3,22.1,Hot flush,17172979
3,6,22.1,Adverse drug reaction,17172979
4,3,22.1,Bradyphrenia,17172979
0,6,22.1,Prostate cancer,17173010
0,6,22.1,Dyspepsia,17173064
1,6,22.1,Somnolence,17173064
2,3,22.1,Neuropathy peripheral,17173064
3,6,22.1,Product dose omission,17173064
4,2,22.1,White blood cell count decreased,17173064
5,6,22.1,Fatigue,17173064
6,6,22.1,Food intolerance,17173064
0,3,22.1,Vascular device infection,17173069
0,6,22.1,Febrile neutropenia,17173088
0,6,22.1,Drug resistance,17173102
1,6,22.1,Malignant neoplasm progression,17173102
2,6,22.1,Metastases to spine,17173102
0,6,22.1,Malignant neoplasm progression,17173103
1,6,22.1,Drug resistance,17173103
0,3,22.1,Breast pain,17173116
1,1,22.1,Dyspnoea,17173116
2,3,22.1,Muscle spasms,17173116
3,3,22.1,Product use issue,17173116
4,3,22.1,Drug ineffective,17173116
0,1,22.1,Cystitis,17173175
1,3,22.1,Haematuria,17173175
0,1,22.1,Ejection fraction decreased,17173201
0,6,22.1,Disease progression,17173247
1,5,22.1,Death,17173247
0,5,22.1,Death,17173252
0,2,22.1,Appendicitis,17173266
1,1,22.1,Injection site pain,17173266
0,2,22.1,Hepatic function abnormal,17173272
0,1,22.1,Hyponatraemia,17173360
0,6,22.1,Bedridden,17173424
0,2,22.1,Cytomegalovirus infection,17173451
1,2,22.1,Gastritis,17173451
0,5,22.1,Interstitial lung disease,17173465
0,6,22.1,Retinopathy,17173542
0,6,22.1,Thyroid cancer,17173556
0,6,22.1,Myelodysplastic syndrome,17173704
0,3,22.1,Fatigue,17173741
0,6,22.1,Neoplasm progression,17173776
0,6,22.1,Neutropenia,17173782
1,6,22.1,Rash,17173782
2,6,22.1,Pyrexia,17173782
0,1,22.1,Rash,17173785
0,3,22.1,Hair colour changes,17173792
1,3,22.1,Hair disorder,17173792
2,3,22.1,Hair texture abnormal,17173792
3,3,22.1,Alopecia,17173792
0,6,22.1,Hypoaesthesia,17173795
0,6,22.1,Full blood count decreased,17173802
0,6,22.1,Arthralgia,17173811
0,3,22.1,Cellulitis,17173840
1,3,22.1,Blood count abnormal,17173840
2,6,22.1,Stomatitis,17173840
3,6,22.1,Product dose omission,17173840
4,6,22.1,Throat irritation,17173840
0,6,22.1,Constipation,17173857
1,6,22.1,Neoplasm progression,17173857
2,6,22.1,Dyspnoea exertional,17173857
3,6,22.1,Fatigue,17173857
4,6,22.1,Lymphadenopathy,17173857
5,6,22.1,Pain,17173857
6,6,22.1,Decreased appetite,17173857
7,6,22.1,Palpitations,17173857
0,,22.1,Dysphagia,17173882
1,,22.1,Hyperhidrosis,17173882
2,,22.1,Tachycardia,17173882
3,,22.1,Infusion related reaction,17173882
4,,22.1,Flushing,17173882
5,,22.1,Dyspnoea,17173882
0,6,22.1,No adverse event,17173910
0,3,22.1,Blood glucose increased,17173930
1,3,22.1,Alopecia,17173930
2,3,22.1,Diarrhoea,17173930
3,3,22.1,Blood pressure increased,17173930
4,6,22.1,Product use in unapproved indication,17173930
5,3,22.1,Fatigue,17173930
6,1,22.1,Gastrooesophageal reflux disease,17173930
0,6,22.1,Diarrhoea,17173931
1,6,22.1,Constipation,17173931
2,1,22.1,Faeces discoloured,17173931
3,6,22.1,Decreased appetite,17173931
4,6,22.1,Incision site complication,17173931
5,6,22.1,Blood pressure diastolic increased,17173931
6,1,22.1,Pain,17173931
7,6,22.1,Gastric disorder,17173931
0,6,22.1,Tumour perforation,17173968
1,6,22.1,Peritonitis,17173968
2,6,22.1,Malignant neoplasm progression,17173968
0,6,22.1,Anaemia vitamin B12 deficiency,17173985
0,6,22.1,Bladder operation,17174007
1,3,22.1,Anxiety,17174007
2,3,22.1,Diarrhoea,17174007
3,6,22.1,Tumour excision,17174007
0,2,22.1,Pyrexia,17174017
1,6,22.1,Viral infection,17174017
2,3,22.1,Diarrhoea,17174017
3,2,22.1,Dehydration,17174017
4,3,22.1,Gastric disorder,17174017
0,6,22.1,Malignant neoplasm progression,17174026
1,6,22.1,Haematotoxicity,17174026
2,6,22.1,Non-small cell lung cancer stage IV,17174026
0,6,22.1,Neoplasm progression,17174049
0,1,22.1,White blood cell count abnormal,17174058
1,1,22.1,Pruritus,17174058
2,1,22.1,Fatigue,17174058
0,6,22.1,Weight decreased,17174064
1,6,22.1,Malaise,17174064
2,6,22.1,Eating disorder,17174064
0,6,22.1,White blood cell count decreased,17174065
0,6,22.1,Peripheral swelling,17174117
1,6,22.1,Adverse event,17174117
2,6,22.1,Decreased appetite,17174117
3,6,22.1,Pollakiuria,17174117
4,6,22.1,Vasculitis,17174117
5,6,22.1,Erythema,17174117
6,6,22.1,Rash vesicular,17174117
0,5,22.1,Death,17174131
0,6,22.1,Back disorder,17174136
1,6,22.1,Nausea,17174136
0,6,22.1,Metastases to bone,17174151
0,6,22.1,Pneumonia,17174186
1,6,22.1,Interstitial lung disease,17174186
2,1,22.1,Pyrexia,17174186
0,2,22.1,Atrial fibrillation,17174260
0,6,22.1,Rhegmatogenous retinal detachment,17174266
0,1,22.1,Pyrexia,17174271
1,1,22.1,Colitis,17174271
0,5,22.1,Death,17174283
1,6,22.1,Fatigue,17174283
2,6,22.1,Nausea,17174283
3,6,22.1,Diarrhoea,17174283
0,2,22.1,Sense of oppression,17174297
1,2,22.1,Throat tightness,17174297
2,2,22.1,Erythema,17174297
0,1,22.1,Peripheral coldness,17174429
1,1,22.1,Erythema,17174429
2,6,22.1,Hot flush,17174429
3,1,22.1,Hypersensitivity,17174429
4,6,22.1,Dizziness,17174429
0,1,22.1,Loss of consciousness,17174444
1,3,22.1,Muscular weakness,17174444
2,6,22.1,Tremor,17174444
3,6,22.1,Nervousness,17174444
4,1,22.1,Confusional state,17174444
5,1,22.1,Pyrexia,17174444
6,2,22.1,Haemoglobin decreased,17174444
0,6,22.1,EGFR gene mutation,17174484
1,6,22.1,Drug resistance,17174484
0,2,22.1,Disease progression,17174524
0,4,22.1,Tumour haemorrhage,17174530
0,3,22.1,Diabetes mellitus,17174606
0,1,22.1,Product dose omission,17174646
0,6,22.1,Hypoaesthesia,17174668
1,6,22.1,Aphasia,17174668
2,6,22.1,Asthenia,17174668
3,6,22.1,Immobile,17174668
4,6,22.1,Movement disorder,17174668
5,6,22.1,Gait inability,17174668
0,5,22.1,Supraventricular tachycardia,17174717
1,5,22.1,Malignant neoplasm progression,17174717
2,6,22.1,Pleural effusion,17174717
3,6,22.1,Tuberculous pleurisy,17174717
4,5,22.1,Non-small cell lung cancer,17174717
0,1,22.1,Anaemia,17174719
1,1,22.1,Neutrophil count abnormal,17174719
2,3,22.1,Metastases to bone,17174719
3,3,22.1,Malignant neoplasm progression,17174719
4,3,22.1,Hypoaesthesia,17174719
5,2,22.1,Red blood cell count decreased,17174719
6,3,22.1,Breast cancer metastatic,17174719
7,3,22.1,Weight decreased,17174719
8,1,22.1,Leukopenia,17174719
9,3,22.1,Abdominal pain upper,17174719
10,2,22.1,Haemoglobin decreased,17174719
11,2,22.1,Haematocrit decreased,17174719
0,5,22.1,Infectious pleural effusion,17174744
0,,22.1,Rectal discharge,17174781
0,1,22.1,Post procedural haemorrhage,17174804
0,,22.1,Bacterial infection,17174822
1,,22.1,Product dose omission,17174822
0,,22.1,Hospitalisation,17174826
0,,22.1,Asthenia,17174850
1,,22.1,Lethargy,17174850
0,,22.1,Death,17174881
0,3,22.1,Gastrointestinal toxicity,17174942
1,3,22.1,Reproductive toxicity,17174942
2,3,22.1,Urinary tract toxicity,17174942
0,5,22.1,Death,17174946
0,5,22.1,Prostate cancer,17174950
0,5,22.1,Death,17174962
0,5,22.1,Death,17174985
1,6,22.1,Inappropriate schedule of product administration,17174985
0,,22.1,Death,17175012
0,6,22.1,Pancreatitis,17175060
1,3,22.1,Dizziness,17175060
2,3,22.1,Hypertension,17175060
3,3,22.1,Eye disorder,17175060
4,6,22.1,Tongue discomfort,17175060
5,6,22.1,Diabetes mellitus,17175060
6,3,22.1,Asthenia,17175060
0,6,22.1,Troponin I increased,17175101
1,6,22.1,Hyperglycaemia,17175101
2,6,22.1,Hypoalbuminaemia,17175101
3,6,22.1,Hypomagnesaemia,17175101
4,6,22.1,Musculoskeletal chest pain,17175101
5,6,22.1,Disturbance in attention,17175101
6,6,22.1,Headache,17175101
7,6,22.1,Memory impairment,17175101
8,6,22.1,Lymphocyte count decreased,17175101
9,6,22.1,Hypocalcaemia,17175101
10,6,22.1,Hypokalaemia,17175101
11,6,22.1,Peripheral sensory neuropathy,17175101
12,6,22.1,Syncope,17175101
13,6,22.1,Neutrophil count decreased,17175101
14,6,22.1,Platelet count decreased,17175101
15,6,22.1,Weight increased,17175101
16,6,22.1,Decreased appetite,17175101
17,6,22.1,Hyperkalaemia,17175101
18,6,22.1,Bone pain,17175101
19,6,22.1,Encephalopathy,17175101
20,6,22.1,Dehydration,17175101
21,6,22.1,Hyponatraemia,17175101
22,6,22.1,Hypophosphataemia,17175101
23,6,22.1,Back pain,17175101
24,6,22.1,Muscular weakness,17175101
25,6,22.1,Myalgia,17175101
26,6,22.1,Peripheral motor neuropathy,17175101
27,6,22.1,Vascular access complication,17175101
28,6,22.1,Alanine aminotransferase increased,17175101
29,6,22.1,Arthralgia,17175101
30,6,22.1,Aspartate aminotransferase increased,17175101
31,6,22.1,Blood creatinine increased,17175101
32,6,22.1,White blood cell count decreased,17175101
33,6,22.1,Posterior reversible encephalopathy syndrome,17175101
34,6,22.1,Troponin T increased,17175101
35,6,22.1,Ejection fraction decreased,17175101
36,6,22.1,Weight decreased,17175101
37,6,22.1,Pain in extremity,17175101
38,6,22.1,Cognitive disorder,17175101
39,6,22.1,Dizziness,17175101
0,2,22.1,Deafness neurosensory,17175286
0,6,22.1,Hypoxia,17175418
1,6,22.1,Hypersensitivity,17175418
2,6,22.1,Hypotension,17175418
3,6,22.1,Hyperpyrexia,17175418
4,6,22.1,Chills,17175418
0,1,22.1,Cardiac failure acute,17175431
0,6,22.1,Colorectal cancer metastatic,17175498
0,6,22.1,Bowel movement irregularity,17175528
1,3,22.1,Paraesthesia,17175528
2,6,22.1,Contusion,17175528
3,6,22.1,Muscle atrophy,17175528
4,6,22.1,Arthralgia,17175528
5,6,22.1,Asthenopia,17175528
6,3,22.1,Polyneuropathy,17175528
7,6,22.1,Diarrhoea,17175528
8,6,22.1,Faeces hard,17175528
9,6,22.1,Myalgia,17175528
10,6,22.1,Insomnia,17175528
11,6,22.1,Sleep attacks,17175528
12,3,22.1,Muscle spasms,17175528
13,3,22.1,Fall,17175528
14,3,22.1,Nervous system disorder,17175528
15,6,22.1,Decreased appetite,17175528
16,6,22.1,Weight decreased,17175528
17,6,22.1,Hunger,17175528
18,6,22.1,Back pain,17175528
19,3,22.1,Hypersomnia,17175528
20,3,22.1,Pain in extremity,17175528
21,6,22.1,Lymphadenopathy,17175528
22,6,22.1,Pruritus,17175528
23,6,22.1,Boredom,17175528
24,3,22.1,Fatigue,17175528
25,3,22.1,Irritability,17175528
26,3,22.1,Bone pain,17175528
0,3,22.1,Drug interaction,17175583
1,6,22.1,Toxicity to various agents,17175583
2,3,22.1,Drug level increased,17175583
3,6,22.1,Renal impairment,17175583
4,6,22.1,Blood creatinine increased,17175583
0,3,22.1,Diarrhoea,17175591
1,6,22.1,Malignant neoplasm progression,17175591
2,2,22.1,Skin discolouration,17175591
3,6,22.1,Drug resistance,17175591
0,6,22.1,Metastases to central nervous system,17175593
1,1,22.1,Vomiting,17175593
2,6,22.1,Discomfort,17175593
3,1,22.1,Headache,17175593
0,1,22.1,Neutrophil count decreased,17175609
1,6,22.1,Drug ineffective,17175609
0,2,22.1,Inappropriate antidiuretic hormone secretion,17175640
0,2,22.1,Neutrophil count increased,17175672
1,1,22.1,Pyrexia,17175672
2,6,22.1,Chemotherapy,17175672
0,6,22.1,Decreased appetite,17175683
1,2,22.1,Embolism venous,17175683
2,1,22.1,Dehydration,17175683
0,3,22.1,Malignant neoplasm progression,17175709
1,5,22.1,Death,17175709
0,6,22.1,Malignant neoplasm progression,17175719
1,6,22.1,PIK3CA-activated mutation,17175719
2,6,22.1,Breast cancer metastatic,17175719
0,6,22.1,Prostatectomy,17175728
1,3,22.1,Mobility decreased,17175728
2,3,22.1,Injection site pain,17175728
0,1,22.1,Neutropenia,17175735
0,3,22.1,Anaemia,17175744
1,6,22.1,Anisocytosis,17175744
2,6,22.1,Haematotoxicity,17175744
3,3,22.1,Malaise,17175744
0,5,22.1,Death,17175771
0,6,22.1,Neutropenia,17175839
1,6,22.1,Neuropathy peripheral,17175839
2,6,22.1,Drug intolerance,17175839
3,6,22.1,Diarrhoea,17175839
4,6,22.1,Thrombocytopenia,17175839
0,3,22.1,Neuropathy peripheral,17175843
1,6,22.1,Palmar-plantar erythrodysaesthesia syndrome,17175843
0,5,22.1,Bronchial haemorrhage,17175862
0,6,22.1,Computerised tomogram liver abnormal,17175923
0,6,22.1,Inappropriate schedule of product administration,17175929
1,6,22.1,Off label use,17175929
0,1,22.1,Device expulsion,17176050
1,1,22.1,Embedded device,17176050
0,3,22.1,Pyrexia,17176304
1,3,22.1,Haemophagocytic lymphohistiocytosis,17176304
2,3,22.1,Hypertriglyceridaemia,17176304
3,3,22.1,Hyperferritinaemia,17176304
4,3,22.1,Pancytopenia,17176304
0,6,22.1,Post procedural haemorrhage,17176341
1,1,22.1,Device deployment issue,17176341
2,6,22.1,Vaginal haemorrhage,17176341
0,3,22.1,Central nervous system vasculitis,17176354
0,1,22.1,Device expulsion,17176459
1,3,22.1,Pregnancy with contraceptive device,17176459
2,6,22.1,Drug ineffective,17176459
0,3,22.1,Pneumonia,17176477
1,6,22.1,Pyrexia,17176477
2,3,22.1,Cough,17176477
3,3,22.1,Dyspnoea,17176477
4,6,22.1,Decreased appetite,17176477
5,3,22.1,General physical health deterioration,17176477
0,6,22.1,Adverse event,17176516
0,6,22.1,Adverse event,17176527
0,6,22.1,Vaginal haemorrhage,17176581
0,3,22.1,Blood urea increased,17176587
1,3,22.1,Blood creatinine increased,17176587
2,3,22.1,Aspartate aminotransferase increased,17176587
3,3,22.1,Blood uric acid increased,17176587
4,2,22.1,Dyspnoea,17176587
5,2,22.1,Pleural effusion,17176587
6,2,22.1,Alanine aminotransferase increased,17176587
7,6,22.1,Weight decreased,17176587
8,1,22.1,Dental caries,17176587
9,2,22.1,Nausea,17176587
0,5,22.1,Second primary malignancy,17176598
1,5,22.1,Acute myeloid leukaemia,17176598
0,6,22.1,Pruritus,17176667
0,5,22.1,Malignant neoplasm progression,17176702
0,6,22.1,Hospitalisation,17176704
0,1,22.1,Chronic kidney disease,17176709
0,6,22.1,Thrombocytopenia,17176711
1,6,22.1,Adverse drug reaction,17176711
2,6,22.1,Dyspepsia,17176711
3,6,22.1,Liver ablation,17176711
4,6,22.1,Eructation,17176711
0,2,22.1,Radiation pneumonitis,17176808
1,6,22.1,Pneumonia,17176808
0,6,22.1,Pain,17176813
1,2,22.1,Radiation pneumonitis,17176813
2,6,22.1,Dehydration,17176813
3,5,22.1,Malignant neoplasm progression,17176813
4,5,22.1,Metastases to central nervous system,17176813
5,6,22.1,Renal failure,17176813
0,6,22.1,Visual impairment,17176822
1,6,22.1,Metastases to central nervous system,17176822
2,6,22.1,Drug resistance,17176822
3,3,22.1,Cough,17176822
4,6,22.1,Malignant neoplasm progression,17176822
0,6,22.1,Lymphoma,17176900
1,6,22.1,Leukaemia,17176900
2,6,22.1,Product use in unapproved indication,17176900
3,6,22.1,Product use complaint,17176900
4,6,22.1,Off label use,17176900
0,6,22.1,Immune-mediated adverse reaction,17176915
0,3,22.1,Measles,17176937
1,3,22.1,Rash,17176937
2,6,22.1,Product use in unapproved indication,17176937
0,6,22.1,Bone marrow failure,17176951
0,6,22.1,Feeling abnormal,17176992
0,3,22.1,Non-small cell lung cancer metastatic,17177209
1,3,22.1,Pleural effusion,17177209
2,3,22.1,Malignant neoplasm progression,17177209
0,5,22.1,Prostate cancer,17177220
0,6,22.1,Tumour marker increased,17177240
1,6,22.1,Metastases to bone,17177240
2,6,22.1,Malignant neoplasm progression,17177240
3,6,22.1,Drug intolerance,17177240
0,2,22.1,Hypersensitivity,17177344
1,2,22.1,Erythema,17177344
2,2,22.1,Feeling hot,17177344
3,2,22.1,Dyspnoea,17177344
4,2,22.1,Chills,17177344
0,3,22.1,Deafness,17177372
1,2,22.1,Insomnia,17177372
2,6,22.1,Rhinorrhoea,17177372
3,3,22.1,Somnolence,17177372
4,6,22.1,Lacrimation increased,17177372
0,6,22.1,Haemorrhage subcutaneous,17177446
1,6,22.1,Injection site induration,17177446
0,6,22.1,Malaise,17177581
0,3,22.1,Non-Hodgkin^s lymphoma,17177613
1,3,22.1,Second primary malignancy,17177613
2,3,22.1,Lymphoma,17177613
3,3,22.1,Cardiac disorder,17177613
